AMA responds to administration blueprint to tackle rising drug prices

| 1 Min Read

CHICAGO — The American Medical Association (AMA) sent the following letter in response to the Trump Administration’s request for comments to its plan to lower drug prices. The letter from AMA CEO and Executive Vice President James L. Madara, M.D., was sent to Health and Human Services Secretary Alex M. Azar II.

 

 

 

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Figures and large health care icons

Geisinger CMO works to cut friction and lift care

| 7 Min Read
Judge's gavel in movement with a virtual text

Don’t open door to more frivolous medical liability lawsuits

| 5 Min Read
Client at a spa appointment

36 states lack regulatory oversight of med spas

| 6 Min Read
Physician points at tablet

After the survey: Turning physician well-being results into change

| 15 Min Read